Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference31 articles.
1. N. Mottet, P. Cornford, R.C.N. van den Bergh, E. Briers, M. De Santis, S. Fanti, S.Gilessen, J. Grummet, A. M. Henry, T. B. Lam, M.D. Mason, T.H. van der Kwast, H.G. van der Poel, O. Rouvière, I.G. Schoots, D. Tilki, T. W. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer.
2. Corfield J, Perera M, Bolton D, Lawrentschuk N (2018) 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review. World J Urol 36:519–527
3. Hofman MS et al (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208–1216
4. Murthy, V. et al. Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial. J. Clin. Oncol. JCO.20.03282 (2021) https://doi.org/10.1200/jco.20.03282.
5. Luiting HB et al (2020) Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. BJU Int 125:206–214
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献